HistoSonics System

DEVICE2 trials

Sponsors

HistoSonics, Inc.

Conditions

Hepatocellular CarcinomaLiver MetastasesLiver Neoplasms

Unknown Phase

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy

Active, not recruitingNCT04572633

HistoSonics, Inc.Hepatocellular Carcinoma, Liver Metastases, Liver Neoplasms

Start: 2021-01-27End: 2027-09-30Updated: 2025-11-19

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)

Active, not recruitingNCT04573881

HistoSonics, Inc.Hepatocellular Carcinoma, Liver Metastases, Liver Neoplasms

Start: 2021-06-04End: 2027-08-31Updated: 2026-01-12

Related Papers

The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors.

2024-09-0144 citations

Clinical experience with a commercial histotripsy system for the ablation of liver tumors

The Journal of the Acoustical Society of America2023-03-01

A Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER).

2022-11-1537 citations